Jinyu Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinyu Zheng has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bing-Hua Chen
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Dongaolei An
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publication - Jin-Yi Xiang
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Lianming Wu
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publication - Mengqi Guo
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publication - Ruoyang Shi
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Pericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Open AccessPericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.